Pathophysiology of neurotrophic keratopathy

Pathophysiology of neurotrophic keratopathy
Leigh Spielberg
Leigh Spielberg
Published: Friday, October 6, 2017
    Professor Harminder Dua Professor Harminder Dua, Queen's Medical Centre, Nottingham, UK, addressed delegates at the 8th EuCornea Congress in Lisbon on the topic of “Pathophysiology of neurotrophic keratoplasty” (NK). “As we all know, the cornea is the most richly innervated structure in the human body, and these nerves have not only sensory functions, but also crucial trophic functions,” said Dr Dua. These trophic functions stimulate the release of neuromediators that provide trophic support to corneal epithelial cells and keratocytes, providing a range of biologically active neurochemicals, such as nerve growth factor (NGF), that contribute to the maintenance of a healthy ocular surface. They are, in turn, supported by trophic substances produced by epithelial cells and keratocytes. “Loss of corneal sensory innervation leads to decreased corneal epithelial renewal rate, reduced tear formation and blinking and ultimately development of NK,” he said. The neurological dysfunction not only lies at the aetiology of the disease, but can also influence the presentation and progression of diseases such as infectious keratitis, with a far less pronounced inflammatory and vascular reaction. This is relevant not only for corneal specialists in tertiary referral centres, but also for general ophthalmologists who perform refractive surgery. Dr Dua noted that: “Even years after LASIK, corneal innervation can remain structurally abnormal. Whether that is functionally important, we don’t yet know, but the ‘pain without stain’ phenomenon might be due to hyper-regeneration of nerves, leading to hyperesthesia and patient complaints.”
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...